Taipei, Taiwan

1-10

Seed

AHEAD: Ai-assisted HEmatologic Analytic and Decision Support

Taipei, Taiwan

1-10

Seed

We focus on developing diagnostic and clinical decision support solutions for hematologic malignancies using artificial intelligence.

Artificial Intelligence

Health Care

Data and Analytics

Hematology, AI, Diagnostic, MedTech, DigitalHealth

About Us

We are a multi-disciplinary team focusing on developing diagnostic and clinical decision support solutions for hematologic malignancies using artificial intelligence. Our co-founders Andrea, Kevin, and Jeremy provide a perfect synergy of data science, clinical medicine, and artificial intelligence expertise. Currently, we have developed a residual leukemia cell detection model (AHEAD-flow) that reduce the interpretation time from 20 minutes to 7 seconds and a relapse/mortality prediction model (AHEAD-mcap) with over 80% accuracy for acute leukemia.

Founder's Corner

Product Feature

Team

Andrea Wang

Co-founder

Kevin Ko

Co-founder

Jeremy Lee

Co-founder

John Li

AI engineer

Selly Lu

AI engineer

Ming-Ya Ko

AI engineer

Press Contact

Andrea Wang

andrea.wang@aheadmedicine.com

+886919393398